Explore

FLEX CLINICALS

Explore

FLEX CLINICALS

Compelling, Consistent Outcomes Data

¹Patients also enrolled in intact vascular study

*Shammas, et al., Femoropopliteal Arterial Dissections Post FLEX Vessel Prep and Adjunctive Angioplasty:  Results of the FLEX iDissection Study, Peripheral Vascular Disease, May 2019

**Zeller, MD, Lopez, MD, and  Pigott, MD, Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions, JET, 2019

Key Indicators:

  • Effective in longer length lesion and real-world plaque morphologies

  • Post-FLEX acute luminal gain ~25%

  • Post-FLEX sub-nominal balloon opening pressures ~4 atm = improved vessel compliance

  • Reduced rate/grade/severity of dissections, with no flow-limiting dissections

  • No perforations or embolizations

Compelling, Consistent Outcomes Data

¹Patients also enrolled in intact vascular study

*Shammas, et al., Femoropopliteal Arterial Dissections Post FLEX Vessel Prep and Adjunctive Angioplasty:  Results of the FLEX iDissection Study, Peripheral Vascular Disease, May 2019

**Zeller, MD, Lopez, MD, and  Pigott, MD, Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions, JET, 2019

Key Indicators:

  • Effective in longer length lesion and real-world plaque morphologies

  • Post-FLEX acute luminal gain ~25%

  • Post-FLEX sub-nominal balloon opening pressures ~4 atm = improved vessel compliance

  • Reduced rate/grade/severity of dissections, with no flow-limiting dissections

  • No perforations or embolizations

¹Subset Analysis

Patient data (N=523 patients; n=583 lesions) collected prospectively and retrospectively from clinics across the Europe and the US

Key Indicators:

  • Effective in longer length lesion and real-world plaque morphologies

  • Post-FLEX acute luminal gain ~25%

  • Post-FLEX sub-nominal balloon opening pressures ~4 atm = improved vessel compliance

  • Reduced rate/grade/severity of dissections, with no flow-limiting dissections

  • No perforations or embolizations

¹Subset Analysis

Patient data (N=523 patients; n=583 lesions) collected prospectively and retrospectively from clinics across the Europe and the US

Key Indicators:

  • Effective in longer length lesion and real-world plaque morphologies

  • Post-FLEX acute luminal gain ~25%

  • Post-FLEX sub-nominal balloon opening pressures ~4 atm = improved vessel compliance

  • Reduced rate/grade/severity of dissections, with no flow-limiting dissections

  • No perforations or embolizations

VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.

VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.